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Abstract
Lipoapoptosis occurring due to an excess of saturated free fatty acids such as palmitate is a key pathogenic event in the
initiation of nonalcoholic fatty liver disease. Palmitate loading of cells activates the endoplasmic reticulum stress response,
including induction of the proapoptotic transcription factor C/EBP homologous protein (CHOP). Furthermore, the loss of
microRNAs is implicated in regulating apoptosis under conditions of endoplasmic reticulum (ER) stress. The aim of this study
was to identify specific microRNAs regulating CHOP expression during palmitate-induced ER stress. Five microRNAs were
repressed under palmitate-induced endoplasmic reticulum stress conditions in hepatocyte cell lines (miR-92b-3p, miR-328-
3p, miR-484, miR-574-5p, and miR-615-3p). We identified miR-615-3p as a candidate microRNA which was repressed by
palmitate treatment and regulated CHOP protein expression, by RNA sequencing and in silico analyses, respectively. There is
a single miR-615-3p binding site in the 39untranslated region (UTR) of the Chop transcript. We characterized this as a
functional binding site using a reporter gene-based assay. Augmentation of miR-615-3p levels, using a precursor molecule,
repressed CHOP expression; and under these conditions palmitate- or tunicamycin-induced cell death were significantly
reduced. Our results suggest that palmitate-induced apoptosis requires maximal expression of CHOP which is achieved via
the downregulation of its repressive microRNA, miR-615-3p. We speculate that enhancement of miR-615-3p levels may be
of therapeutic benefit by inhibiting palmitate-induced hepatocyte lipoapoptosis.
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Introduction
The molecular pathogenesis of the highly prevalent chronic
liver disease, nonalcoholic fatty liver disease (NAFLD) is not fully
understood [1,2]. Progressive forms of NAFLD, termed nonalco-
holic steatohepatitis (NASH) are characterized by hepatocyte
apoptosis, which correlates with disease severity as well as disease
progression to cirrhosis [3]. Circulating free fatty acids (FFA) are
elevated in NASH, and when elevated induce apoptosis of cells, a
process termed lipoapoptosis [4,5]. It is postulated that FFA-
induced hepatocyte apoptosis is a key pathogenic event in the
progression of NASH, which is increasingly viewed as a lipotoxic
disease. Recent studies have linked endoplasmic reticulum (ER)
stress and microRNAs (miRs) to NAFLD.
MicroRNAs are small noncoding RNAs increasingly recognized
in modulating the cellular response to stress [6]. MicroRNAs bind
to complementary seed sequences in the 39untranslated region
(39UTR) of their target mRNA, resulting in either target mRNA
degradation, or attenuation of translation. Thus, by post-
transcriptionally regulating the expression of their target proteins,
microRNAs are able to fine tune cellular protein levels and thus a
cell’s response to stress. MicroRNA profiling has shown that
microRNAs are modified in NAFLD in humans and in rodent
models, however, the functional consequences of these changes
have not been fully elucidated [7,8]. One of the described links
between microRNAs and lipoapoptosis, demonstrated that micro-
RNA-296 contributed to apoptosis by targeting the proapoptotic
protein PUMA [9]. Furthermore, recent studies have linked
microRNAs to ER stress pathways; however, the role of
microRNAs in regulating ER stress-induced cell death under
lipotoxic conditions has not been explored.
ER stress is a recognized feature of NAFLD, and one of the
molecular pathways implicated in hepatocyte lipoapoptosis down-
stream of ER stress is C/EBP homologous protein (CHOP)-
mediated cell death [10]. In addition, palmitate can activate the ER
stress response, including CHOP expression in many cell types,
including Chinese hamster ovary cells, cardiomyocytes, fibroblasts,
INS-1E cell line and pancreatic beta cells [11,12,13]. In these
models increased ER membrane saturated lipid content and ER
calcium depletion are implicated as mechanisms. CHOP is a
transcription factor, expressed at very low levels under normal
conditions [14]. Cellular stress, including endoplasmic reticulum
(ER) stress transcriptionally activates the expression of CHOP,
wherein, CHOP is implicated in the ensuing apoptosis [15].
PLOS ONE | www.plosone.org 1 October 2014 | Volume 9 | Issue 10 | e109637
Furthermore, mice deficient in CHOP (Chop-/-) are protected from
tunicamycin-induced liver and kidney injury. Increased protein
synthesis rates and modulation of the death receptor, death receptor
5, and Bcl-2 family proteins have been proposed as possible
mechanisms for CHOP-dependent cell death [16,17,18,19].
Furthermore, recent studies have linked microRNAs to the
regulation of ER stress-induced cell death [20]. However, the
specific role of microRNAs that repress CHOP under lipotoxic
conditions remains unexplored.
In this study we have identified that the lipotoxic saturated free
fatty acid, palmitate, induces ER stress, and a concomitant
decrease in microRNA miR-615-3p levels, thus derepressing
CHOP protein expression. Using gain-of-function and loss-of-
function approaches we demonstrate that this microRNA regu-
lates CHOP expression and cell death. Analysis of mouse liver
samples with NASH demonstrates decreased miR-61-3p levels
with concomitant increase in CHOP protein levels.
Materials and Methods
Cells
Neonatal mouse hepatocytes were derived from wild-type or
IRE1a knockout mice, as previously described, and immortalized
with SV40 large T antigen and were a gift from Dr. Randal
Kaufman [21]. The mouse hepatoma cell line Hepa 1–6 was
obtained from ATCC. Primary mouse hepatocytes were isolated
and percoll purified from C57BL/6 male mice by collagenase-
based liver perfusion as previously described, and utilized for
experiments only if greater than 95% viable [22]. The use of mice
for isolation of hepatocytes was reviewed and approved by the
Institutional Animal Use and Care Committee, Mayo Clinic,
Rochester. The well-established human liver cell line, Huh7
(JCRB Cell Bank,# JCRB0403, derived from a well-differentiated
hepatocellular carcinoma from a 57 year old male) was cultured as
described [23].
Fatty acid treatment
Palmitic acid (PA) was purchased from Sigma-Aldrich. Albu-
min-bound PA was applied to cells as previously described by us
[24].
MicroRNA expression analysis
MicroRNAs were isolated from cells using the miRNeasy mini
kit (Qiagen) according to the manufacturer’s instructions.
Sequencing was performed at the Medical Genomics Facility,
Mayo Clinic, Rochester, MN. Briefly, microRNAs were se-
quenced using the NEBNext Small RNA library prep kit on an
Illumina HiSeq 2000. The Illumina reads were trimmed of
adapters with Cutadapt [25]). Trimmed microRNA sequences
greater than 17 nucleotides in length were then aligned to the
mm9 reference genome and the miRBase v19 reference sequences
using Bowtie [26]. Known microRNA expression and novel
microRNA prediction were quantified using the miRDeep2
package [27]. Differential expression analysis was performed with
the Bioconductor R package EdgeR [28]. Individual microRNAs
were amplified by Taqman assays (Applied Biosystems) for mmu-
miR-615-3p and has-miR-615-3p (P131015-004E01) and normal-
ized to the expression of sno-202 (P131022-004H07) for mouse,
and U47 (P140221-004G06) for human, to calculate the dCT.
Relative expression was expressed as fold change using the ddCT
method, as described [29].
Total RNA isolation and quantitative PCR
Total RNA was isolated from cells using the RNeasy mini kit
(Qiagen) according to the manufacturer’s instructions. Reverse
transcription was performed using the iScript cDNA synthesis kit
(BioRad). Quantitative real-time PCR (qPCR) reactions were run
on the LightCycler 480 (Roche), using the LightCycler 480 SYBR
Green 1 Master (Roche). The following primers were used: Chop
FP-59-CTGCCTTTCACCTTGGAGAC-39 and RP-59-
CGTTTCCTGGGGATGAGATA-39, and HPRT FP- 59-
TCCTCCTCAGACCGCTTTT-39 and RP 59-
CCTGGTTCATCATCGCTAATC-39. Relative mRNA expres-
sion was expressed using the method of Livak and Schmittgen
[29].
Transfection and Labeling
Cultured cells were transfected with Opti-MEM I Reduced-
Serum Medium (catalog#31985-070, Life Tecnologies, Grand
Island, NY), X-treme Gene siRNA Transfection Re-
agent(catalog#0447609300, Roche, Mannheim, Germany), miR-
CURY LNA Inhibitor Control (Negative control A cat-
alog#199004-00, 5nmol, EXIQON, Woburn, MA), miRCURY
LNA Inhibitor (hsa-miR-615-3p catalog#411356-00,
Batch#224134, 5 nmol, EXIQON, Woburn, MA), mirVana
microRNA mimic negative control #1(catalog#4464058,
Lot#ASO0VDIQ, 5 nmol, Ambion, Grand Island, NY), mirVana
microRNA mimic hsa-miR-615 (catalog#4464066, 5 nmol,
Ambion, Grand Island, NY). Using Ambion by Life Technologies
Silencer siRNA Labeling Kit-Cy3 (cat # AM1632) according to
manufacturer’s instructions for labeling duplex siRNA we labeled
50 mM negative control #1 or mirVana microRNA mir-615-3p
mimic.
Protein isolation and Western Blotting
Proteins were extracted using RIPA buffer, resolved by SDS
PAGE on commercially available Criterion acrylamide gels
(BioRad), and electroblotted onto polyvinylidene fluoride (PVDF)
membrane. 5% non-fat dairy milk in Tris-buffered saline (20 mM
Tris, 150 mM NaCl, pH 7.4) with 0.1% Tween-20 or LICOR
Blocking Buffer (LiCor Biosciences, Lincoln, NE) were used to
block non-specific binding sites. Blots were incubated with primary
antibodies at 4uC overnight and with secondary antibodies at
ambient temperature for 1 hour. The following primary antibodies
were used: mouse monoclonal Ab to CHOP (sc-7315, 1:100,
Santa Cruz Biotechnology, Dallas, TX), rabbit polyclonal Ab to
CHOP (sc-793, 1:100, Santa Cruz), rabbit polyclonal Ab to
activating transcription factor-4 (ATF4) (sc-200, 1:200, Santa
Cruz), rabbit polyclonal Ab to the alpha subunit of eukaryotic
initiation factor phosphorylated at serine 52 (p-eIF2a, 44–728G,
1:1000, Invitrogen), rabbit polyclonal antibody to eIF2a (9722,
1:1000, Cell Signaling), mouse monoclonal Ab to glyceraldehyde-
3-phosphate dehydrogenase (GAPDH, MAB374, 1:10,000, Milli-
pore) and c-Tubulin (T6557, 1:5000, Sigma Pharmaceuticals, St.
Louis, MO). HRP conjugated secondary antibodies; goat anti-
mouse (sc-2005, 1:3000, Santa Cruz) and goat anti-rabbit (sc-
2004, 1:3000, Santa Cruz) were used to detect antigen-antibody
complexes. Infrared dye conjugated secondary antibodies; donkey
anti-rabbit (926–32213, 1:20,000, LiCor) and donkey anti mouse
(926–68072, 1:20,000, LiCor) were used for detection by the
Odyssey infrared imager. Immune complexes were visualized
using a chemilunimescent substrate (ECL, Amersham, IL), and
Kodak XOMAT film (Eastman Kodak, Rochester, NY) or by
Odyssey Imager (LI COR Biosciences, Lincoln, Nebraska). NIH
Image J software was used for densitometric quantification of
miR-615-3p Is Antiapoptotic during ER Stress
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CHOP expression, consistently under induced conditions, and
when detected under basal conditions.
Luciferase Assay
The region of the wild-type Chop mRNA (also known as Ddit3)
39UTR with a putative miR-615-3p binding site or mutant Chop
mRNA 39UTR were cloned into pMIR-REPORT Luciferase
vector (cat # AM5795, Applied Biosystems) using Spe I and Hind
III sites. The sequences of the putative binding site and the regions
targeted by mutagenesis and cloned into the reporter gene are
depicted in Figure S1. All plasmids were verified by sequencing.
These constructs were transfected into Hek293A cells using
Lipofectamine LTX with Plus Reagent (cat #18324-012, Life
Technologies). Cells were plated at a density of 3600/cm2
{(16104) per well} per well, into a 96-well plate and attached
overnight. They were co-transfected with 100 ng of wild-type or
mutant reporter vector, 10 ng of internal control pRL-TK-
Renilla-luciferase plasmid (cat# E2241, Promega) and negative
control #1 or mirvana microRNA miR-615-3p mimic, both from
Life Technologies final concentration, 80 nM. Twenty four hours
post-transfection, luciferase activities were measured using the
Dual-Glo Luciferase Assay System (cat # E2920, Promega)
according to the manufacturer’s instructions. Firefly luciferase
values were normalized by dividing by the Renilla luciferase
values.
Apoptosis assessment
Apoptosis was quantified by nuclear morphologic changes of
apoptosis following staining with 49,6-diamidino-2-phenylindole
(DAPI). Apoptotic cells were counted under fluorescence micros-
copy, and expressed as a percent of total cells. Three hundred to
four hundred total cells were counted per condition per replicate.
For apoptosis assessment with the mirVana miR-615-3p mimic,
only cells which were transfected with the fluorescently labeled
mimic were included. Six hours after the transfection, cells were
treated with either palmitate or tunicamycin for 18 hours, fixed
using 10% neutral buffered formaldehyde, mounted in Prolong
Antifade Gold with DAPI (cat # P36935, Life Technologies) and
counted under fluorescence microscopy. To confirm apoptosis,
caspase 3/7 activity was measured biochemically using a
commercially available homogeneous luminescent assay, Caspase
3/7-Glo (cat # G-8091, Promega Corporation, Madison, WI).
Briefly, an equal volume of the reaction mixture (containing lysis
buffer and a proluminescent caspase 3/7 substrate) was added to
each well of the 96 well plate, and luminescence was acquired with
a plate reader (Biotek Corporation,
Mouse Liver Studies
Archived total RNA from mice fed either chow (n= 7) or the
high fructose, high fat, high cholesterol diet (n = 13), and whole
liver protein extracts from chow-fed mice (n = 3) and high fructose,
high fat, high cholesterol diet-fed mice (n = 8) were a kind gift of
Dr. Charlton. This is a bona fide model of human NASH,
recapitulating key metabolic and liver features of this disease [30].
The studies conducted by Dr. Charlton et al were done with
review and approval by the Institutional Animal Care and Use
Committee, Mayo Clinic.
Reagents
49, 6-diamidino-2-phenylindole (DAPI), isopropanol, bovine
serum albumin, and palmitic acid were from Sigma Pharmaceu-
ticals (St. Louis, MO). Tunicamycin was from Calbiochem.
Statistical Analysis
Data are presented as the means 6S.E.M. from three or more
independent experiments unless indicated otherwise. Statistical
analysis was performed using two-tailed t tests. p,0.05 was
considered a significant difference.
Results
MicroRNAs decreased by palmitate treatment
Due to our interest in lipotoxicity and endoplasmic reticulum
(ER) stress, we utilized previously described mouse hepatocyte-
derived cell lines to identify microRNAs (miRs) that were
downregulated by palmitate treatment and tunicamycin-induced
ER stress [21]. The cell lines utilized were derived from wild-type
hepatocytes (IRE-WT) and from hepatocytes deficient in IRE1a
(IRE-KO) expression. We first identified microRNAs downregu-
lated by palmitate (400 mM, 16 hours) or tunicamycin (1 mg/mL,
16 hours) in IRE-WT and IRE-KO hepatocytes by pair-wise
comparisons of microRNAs downregulated under these conditions,
compared to vehicle treated cells (Data S1-S4). We employed this
approach in order to avoid identifying microRNAs that were
potentially targeted by the recently described microRNA-processing
activity of IRE1a [20]. We identified five common miRs which were
downregulated by both palmitate and tunicamycin in both wild-type
and IRE1a deficient hepatocytes (Table 1).
Due to the known proapoptotic role of CHOP under ER stress
conditions, we next focused on miRs which might regulate CHOP
expression and thus ER stress-induced apoptosis. Using computa-
tional tools we assessed each of the five miR’s presented in Table 1
as potential regulators of CHOP, and we consequently narrowed
our search to miR-615-3p as a miR which might regulate CHOP
expression, which is encoded by the DNA-damage-inducible
transcript 3 (Ddit3) gene. Computational searches yielded no fully
conserved sites for miR-615-3p binding in the Chop 39UTR across
several species; however, several computational approaches predict-
ed a single binding site for miR-615-3p in the mouse Chop 39UTR
(TargetScan, miRanda, miRWalk) (Figure 1A). We next identified
a potential miR-615-3p binding site in the human CHOP 39UTR
based on minimum free energy (mfe) using the program RNAhybrid
at http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/ [31]. Prefer-
ences were set to allow G:U wobble bases within the alignment; these
are indicated in the figure 1B. For each binding site, the sequence
alignment is shown as well as a schematic line diagram of the
predicted complementary regions and bulges. While the exact
binding sequence was not conserved, the relative position in the
39UTR is the same. For reference, the last 6 bases shown of the
miR-615-3p binding site on human CHOP (UUGGAG) corre-
spond to the first 7 bases of the miR-615-3p binding site on mouse
Chop (CUGAGGG) in a region of ,68% identity by ClustalW
alignment. Thus, we concluded that potential miR-615-3p binding
Table 1. MicroRNAs downregulated by palmitate and








miR-615-3p Is Antiapoptotic during ER Stress
PLOS ONE | www.plosone.org 3 October 2014 | Volume 9 | Issue 10 | e109637
sites exist in the 39UTR of the CHOP gene in both mouse and
humans.
We next confirmed our RNA sequencing data, that palmitate and
tunicamycin treatment decreased miR-615-3p expression levels in
IRE1a wild-type and knockout cells. We did not see a significant
reduction in miR-615-3p following 12 hours of treatment with PA
or tunicamycin (Figure S2A and S2B). A significant reduction in
miR-615-3p levels was observed at 16 hours of treatment
(Figure 2A and 2B). This occurred before significant apoptosis
was observed in these cell lines (Figure S2C and S2D) and
coincided with robust induction of CHOP expression (Figure
S2Eand S2F). CHOP protein levels were undetectably low in IRE-
WT cells at 8 hours, and were detected at a low level at 8 hours in
IRE-KO cells; however, the CHOP protein expression peaked at
16 hours, before the onset of apoptosis. Next, we verified that this
occurred in isolated primary mouse hepatocytes and Hepa1-6 cells
(Figure 2C and 2D). Indeed, in all four mouse cultured cells tested,
palmitate and tunicamycin treatment significantly reduced miR-
615-3p levels. Consistent with the mouse data, we observed a
significant reduction in miR-615-3p in the human liver cell line,
Huh7 (Figure 2E).
Mmu-miR-615-3p regulates CHOP expression
We next pursued a gain-of-function approach utilizing a mmu-
miR-615-3p mimic to inhibit CHOP expression. As previously
described by us and others [10,32], low-level basal CHOP
expression was detected in wild-type mouse liver cells (IRE-WT)
and mouse hepatoma cell line, Hepa 1-6, Figure 3A and 3B,
respectively. CHOP was induced by both PA and tunicamycin in
these cells. Kinetic analysis of CHOP protein expression showed a
significant increase in protein levels before the onset of apoptosis
(Figures S2C-S2F). As predicted, in cells transfected with a
precursor of miR-615-3p, PA-induced and tunicamycin-induced
CHOP expression was significantly abrogated (Figure 3A – 3D).
CHOP is induced transcriptionally under ER stress conditions.
These data suggest that under ER stress conditions, once CHOP
expression is induced, microRNA miR-615-3p confers a level of
post-transcriptional regulation, such that the reduction of miR-615-
3p under ER stress conditions, derepresses CHOP protein
expression.
We next utilized a loss-of-function approach, using an antagomir
targeting miR-615-3p. CHOP levels were low basally, and did not
significantly increase with the antagomir treatment (Figure 3E),
suggesting that miR-615-3p does not regulate basal levels of
CHOP expression. These data are consistent with the concept that
ER stress is required to increase CHOP expression [15]. Nor did we
see a significant further increase in CHOP protein expression in
PA- and tunicamycin-treated cells (Figure S3), suggesting that
maximal CHOP expression under these conditions had already
occurred due to the transcriptional upregulation of CHOP under
ER stress conditions. Thus, as maximal expression was achieved, it
could not be further increased by antagonizing mir-615-3p, levels
of which are already reduced by both PA and tunicamycin
treatment, as shown in Figure 2. Thus, under ER stress conditions,
Figure 1. Computationally identified miR-615-3p binding site in ChopmRNA. (A) Schematic representation of the sequence for mouse Chop
mRNA showing a section of the 39 untranslated region (UTR) and the mmu-miR-615-3p sequence below. The 7-mer binding site is depicted by the
solid lines at the 39 end of the Chop mRNA. (B) Sequence of a section of the human 39UTR of the CHOP mRNA, with the potential mir-615-3p binding
site is depicted. For each binding site, the sequence alignment is shown as well as a schematic line diagram of the predicted complementary regions
and bulges. The predicted minimum free energy (mfe) is depicted. Preferences were set to allow G:U wobble bases within the alignment; these are
indicated in the figure.
doi:10.1371/journal.pone.0109637.g001
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when CHOP expression is transcriptionally induced, miR-615-3p
regulates its expression; by coordinately decreasing miR-615-3p
levels maximal expression of CHOP is achieved by PA and
tunicamycin.
Mmu-miR-615-3p binds the 39UTR of Chop
We confirmed direct binding of the Chop mRNA by miR-615-3p
by employing a luciferase-based reporter assay. The sequence of the
miR-615-3p binding site in the Chop 39UTR is shown in
Figure 1A. This was cloned into the 39UTR of the luciferase
reporter pMIR-report vector as described under materials and
methods. As a control, we mutated the seed sequence and strong
complementarity along the full length of the binding site in the
39UTR of the Chop transcript so as to abrogate miR-615-3p
binding (Figure S1). In cells co-transfected with the reporter
construct and miR-615-3p mimic, a significant reduction in the
Figure 2. Palmitate treatment decreases miR-615-3p levels. (A) Neonatal IRE1a wild-type hepatocyte cells (IRE-WT) were treated with 400 mM
palmitate (PA) or 1 mg/mL tunicamycin (tuni) for 16 hours. Control cells were treated with vehicle alone (VC). * P,0.05 compared to VC. (B) Neonatal
IRE1a knockout (IRE-KO) cells were treated with 400 mM palmitate (PA) or 1 mg/mL tunicamycin for 16 hours. Control cells were treated with vehicle
alone (VC). * P,0.05 compared to VC (C) Primary mouse hepatocytes (PMH) were treated with 400 mM palmitate (PA) or 1 mg/mL tunicamycin for
16 hours. Control cells were treated with vehicle alone (VC). * P,0.05 compared to VC. (D) Hepa1-6 cells were treated with 400 mM palmitate (PA) or
1 mg/mL tunicamycin for 24 hours. Control cells were treated with vehicle alone (VC). * P,0.05 compared to VC. (E) Huh7 cells were treated with
400 mM palmitate (PA) or 1 mg/mL tunicamycin for 30 hours. Control cells were treated with vehicle alone (VC). * P,0.05 compared to VC.
doi:10.1371/journal.pone.0109637.g002
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luciferase activity was observed (Figure 4). Furthermore, cells
transfected with the mutated binding site containing reporter and
the miR-615-3p mimic demonstrated no reduction in luciferase
activity. These data confirm that miR-615-3p functionally and
directly binds to the Chop 39UTR.
MiR-615-3p mimic confers resistance to cell death
Having demonstrated a functional binding site for miR-615-3p
in the Chop transcript, and regulation of CHOP protein levels by
this mechanism, we next asked if miR-615-3p regulates sensitivity to
PA-induced apoptosis. Utilizing a precursor of miR-615-3p, to
inhibit CHOP expression, we observed a significant reduction in
Figure 3. MiR-615-3p inhibits CHOP expression. (A) Representative western blot for CHOP in IRE-WT cells treated with 400 mM palmitate (PA) or
1 mg/mL tunicamycin (tuni) for 16 hours. The cells were transfected with either a negative control, or a precursor of miR-615-3p (pre-miR-615-3p).
Molecular weights are indicated in kDa. The immune complexes were detected using an infrared fluorescent imaging system. Alpha-tubulin was used
as loading control. (B) Quantification of CHOP protein levels normalized to tubulin, under the same conditions as A, expressed relative to the negative
control mimic treated cells for each condition, respectively. ** P,0.01. (C) Representative western blot for CHOP in Hepa 1–6 cells treated with
400 mM palmitate (PA) or 1 mg/mL tunicamycin for 24 hours. The cells were transfected with either a negative control, or a precursor of miR-615-3p
(pre-miR-615-3p). Molecular weights are indicated in kDa. The immune complexes were detected using enhanced chemiluminescence. Alpha-tubulin
was used as loading control. The middle panel (**) depicts a longer film exposure of the top panel (*) (D) Quantification of CHOP protein levels
normalized to tubulin, under the same conditions as C, expressed relative to the negative control mimic treated cells for each condition, respectively.
* P,0.05, ** P,0.01 (E) Representative western blot for CHOP in IRE-WT and Hepa1-6 cells in cells transfected with either an antagomir to miR-615-p
or a negative control antagomir. Alpha-tubulin was used as loading control. (F) Quantification of CHOP protein levels normalized to tubulin, under
the same conditions as E, expressed relative to the negative control antagomir treated cells for each condition, respectively. P = ns.
doi:10.1371/journal.pone.0109637.g003
miR-615-3p Is Antiapoptotic during ER Stress
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PA-induced and tunicamycin-induced apoptosis (Figure 5A). We
confirmed apoptosis biochemically by caspase 3/7 activation
(Figure 5B), which paralleled the morphologic assessment of
apoptosis. As we utilized a fluorescently labeled precursor molecule,
in our morphologic assessment, we only counted cells that were
positively transfected. Our transfection efficiency was greater than
90%; however, in the caspase 3/7 assay all cells are assayed,
therefore, the magnitude of reduction was somewhat mitigated.
Furthermore, the miR-615-3p precursor only partially suppressed
CHOP expression as shown in Figure 3, which corresponds with the
partial resistance to apoptosis under similar conditions.
MiR-615-3p levels are reduced in nonalcoholic
steatohepatitis
To further explore the potential role for miR-615-3p in
regulating lipoapoptosis in vivo, we interrogated the expression of
this microRNA in archived liver RNA samples from chow fed mice
and mice fed a diet high in fructose, fat and cholesterol (FFC) for 6
months. The liver injury and metabolic syndrome induced by this
diet recapitulates human obesity-associated NASH and has been
well characterized [30]. We detected miR-615-3p in whole liver
RNA in chow fed mice. Furthermore, in FFC-fed mice the
expression of miR-615-3p was significantly reduced (Figure 6A),
consistent with our in vitro observations. CHOP protein expression
was increased in FFC-fed mice (Figure 6B), as was the expression
of ATF4, and phosphorylation of eIF2a, supporting in vivo
activation of the protein kinase RNA-like ER kinase (PERK)
signaling axis in FFC-fed mice. CHOP levels were very low in chow
fed mice as previously reported [14], and induced by FFC feeding.
We conclude that hepatic miR-615-3p levels are reduced by a diet
high in fructose, fat and cholesterol, which might be a mechanism
for the increase in CHOP protein expression. FFC-fed wildtype
mice demonstrate a concomitant increase in hepatocyte lipoapoptosis
(Idrissova et. al., under review).
Discussion
In this study we have demonstrated that the microRNA mmu-
miR-615-3p is reduced under conditions of endoplasmic reticulum
(ER) stress, wherein it regulates the expression of C/EBP
homologous protein (CHOP) and determines cellular sensitivity
to cell death. The principal findings that support these conclusions
are: 1) mmu-miR-615-3p levels are reduced under conditions of
ER stress; 2) there is a functional miR-615-3p binding site in the
39UTR of the Chop mRNA; and 3) ER stress-induced cell death is
reduced by miR-615-3p-dependent CHOP repression.
In the current study we utilized mouse hepatocyte cells lines,
primary mouse hepatocytes and a human hepatocellular carcino-
ma-derived cell line. MicroRNA miR-615-3p was detected in five
different hepatocyte cell lines. We demonstrate that under
palmitate-induced ER stress the levels of miR-615-3p are reduced
in all five cell lines tested. It is also detected in rat cholangiocyte
cell lines (Dr. LaRusso, personal communication). We used
palmitate to induce ER stress, as it is a physiologically abundant
free fatty acid, whose levels are further elevated in obesity-
associated fatty liver disease, wherein, it is implicated as the
stimulus for cellular demise[4,5]. We additionally chose to include
tunicamycin as an independent inducer of ER stress as a positive
Figure 4. Chop mRNA is a direct target of miR-615-3p. A region
of the Chop 39UTR containing the putative miR-615-3p binding site was
cloned into the pMIR-report vector downstream of the luciferase coding
region (p-MIR-Chop). The 39UTR segment with the putative miR-615-3p
binding site mutated (p-MIR-Chop-mut) was also cloned into the pMIR-
report vector. HEK293 cells were co-transfected with the respective
reporter plasmid and precursor of miR-615-3p (pre-miR-615-3p) or a
negative control precursor molecule. Relative luciferase activity
(normalized to renilla) was measured 24 hours after the transfection.
Data are expressed relative to the wild-type binding site transfected
cells treated with a negative control precursor molecule and (n = 5
independent experiments), * P,0.05.
doi:10.1371/journal.pone.0109637.g004
Figure 5. MiR-615-3p reduces palmitate-induced cell death. (A)
Neonatal liver wild-type cells were transfected with either the negative
control precursor or precursor of miR-615-3p, both fluorescently labeled
with Cy3. 8 hours after transfection, cells were treated with 400 mM
palmitate (PA) or 1 mg/mL tunicamycin for 18 hours. DAPI stained
nuclei were counted in each condition. * P,0.05. (B) Neonatal liver wild-
type cells were transfected with either the negative control precursor or
precursor of miR-615-3p. 8 hours after transfection, cells were treated
with 400 mM palmitate (PA) or 1 mg/mL tunicamycin for 18 hours.
Caspase 3/7 activity was measured as described. * P,0.05.
doi:10.1371/journal.pone.0109637.g005
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control [33]. We and others have shown that palmitate treatment
activates the proximal unfolded protein response sensors and leads
to CHOP expression [11,12,13,32]. These studies have mecha-
nistically demonstrated an increase in membrane lipid saturation,
and ER calcium depletion upon palmitate loading.
Mmu-miR-615-3p has a single predicted binding site in the
Chop (ddit3) 39UTR. The Chop 39UTR is one hundred and
ninety five nucleotides in length, with few computationally
identified microRNA binding sites. Additionally, we have identi-
fied a potential miR-615-3p binding site in the human CHOP
39UTR. A microRNA which is transcriptionally regulated by
CHOP, miR-708, has been previously described [34]. This
microRNA is induced by ER stress, and represses rhodopsin, thus
limiting the amount of new rhodopsin entry in to the ER. Mir-211
is transcriptionally induced under ER stress conditions by PERK
and ATF4, with subsequent repression of CHOP transcription by
causing promoter hypermethylation [35]. ER stress repressed the
cluster miR-106b,25 via ATF4 and Nrf2 allowing increased Bim
protein expression and apoptosis [36]. MiR-615-3p adds to the
growing cache of microRNAs linked to the ER stress response.
Augmentation of miR-615-3p activity by exogenous administra-
tion of a precursor repressed CHOP levels; however, we did not
observe any further augmentation of the expression of CHOP by
antagonizing miR-615-3p. Our data suggests that the reduction of
this microRNA by palmitate facilitates maximal expression of
CHOP protein under conditions of palmitate-induced ER stress,
but does not contribute to its basal regulation. Furthermore, we
observed a similar reduction in miR-615-3p levels in a mouse liver
cell line deficient in IRE1a. This suggests that miR-615-3p is not
targeted by the RNase activity of IRE1a. However, this does not
exclude regulation of miR-615-3p by the other signaling pathways
that comprise the UPR, viz. PERK and ATF6. Systematic
dissection of these pathways will be our focus in future studies.
Palmitate-induced hepatocyte lipoapoptosis is thought to be one
of the key cellular mechanisms underlying disease onset and
progression in nonalcoholic steatohepatitis. Palmitate induces ER
Figure 6. MiR-615-3p and CHOP levels in nonalcoholic steatohepatitis. (A) MiR-615-3p levels were measured in mouse liver from chow fed
mice (n = 7) and mice with nonalcoholic steatohepatitis induced by feeding a diet high in fructose, fat and cholesterol (FFC) for 6 months (n = 13). Bars
depict mean 6S.E.M, * P,0.05. (B) Immunoblots for p-eIF2a, total-eIF2 a, ATF4, CHOP and GAPDH for loading control from whole liver protein
extracts from chow fed mice (n = 3) and FFC-fed mice (n = ). The arrow points to the predicted CHOP band in the immunoblot.
doi:10.1371/journal.pone.0109637.g006
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stress in hepatocytes and many other cell types. We have now
demonstrated that palmitate-induced apoptosis is partially CHOP-
dependent. The miR-615-3p precursor partially reduced palmitate
and tunicamycin-induced CHOP levels. This is likely why a partial
reduction in palmitate and tunicamycin-induced apoptosis was
observed. A previous study had demonstrated that the genetic
deletion of CHOP did not protect the hepatocyte from palmitate-
induced apoptosis [32]. However, in this study hepatocytes were
treated with 200 mM palmitate for 16 hours; these conditions in
our hands do not result in significant apoptosis [23,24]. In the
present study a higher concentration of palmitate was used, i.e.,
400 mM, and this resulted in significant apoptosis at a longer
duration of treatment (24 hours). Furthermore, others have
demonstrated a reduction in palmitate-induced apoptosis upon
silencing of CHOP expression in human hepatoma cells [10]. In
these studies we have not focused on events downstream of CHOP
induction; however, recent literature suggests a possible induction
of the TRAIL receptor, death receptor 5 by CHOP as a pro-
apoptotic signal under ER stress conditions [17]. Alternatively,
increased protein synthesis has been implicated as a mechanism
for CHOP-induced cell death [16]. In the later study DR5 was not
a transcriptional target of CHOP. Therefore, it will be interesting
to observe in future studies which of these mechanisms is
operational during hepatocyte lipoapoptosis.
In this study we have demonstrated a reduction in miR-615-3p
by palmitate. Palmitate can repress gene expression by epigenetic
changes resulting in promoter hypermethylation [37]. As the miR-
615-3p coding region is located within intron 1 of the Hoxc5 gene
on chromosome 15, these data suggest that palmitate can repress
the expression of this genetic locus. This is one possible
explanation for palmitate-induced reduction in miR-615-3p levels,
and will require further studies to elucidate, which is not the focus
of the current manuscript. We do provide evidence that repression
is independent of the ER-stress responsive kinase and RNase
IRE1a, as we observed similar repression in IRE1a-deficient cells.
MicroRNAs are altered in the liver in NASH, and it has been
proposed that circulating microRNAs or microRNAs present on
microvesicles may serve as a biomarker for NASH. Our
observations have identified a new candidate microRNA, miR-
615-3p, levels of which are significantly repressed in the liver in
NASH for such studies.
In summary, these data support a model that palmitate lowers
miR-615-3p levels, thus derepressing CHOP expression under
conditions of ER stress, consequently promoting lipoapoptosis. We
have identified a mechanism for ER stress-induced apoptosis
which relies on the maximal expression of CHOP by the inducing
stimulus, palmitate, in this case. We suggest that augmentation of
miR-615-3p activity is an attractive target for decreasing
lipoapoptosis.
Supporting Information
Figure S1 Sequences of wild-type and mutated miR-615-
3p binding sites in Chop 39UTR. (A) Sequence of the region
containing the predicted binding site for miR-615-3p in the
39UTR of the Chop transcript was cloned into the pMIR reporter
to generate a luciferase reporter plasmid, we have designated
pMIR-ddit3, as described in Materials and Methods. The
nucleotides which were altered to generate a mutated plasmid,
which we designated pMIR-ddit3-mut are underlined. The seed
region complementary nucleotides are in bold. (B) The sequence
of the mutated pMIR-ddit3-mut is depicted. The altered
nucleotides are in italics. (C) Mutagenesis of the miR-615-3p
binding site within the mouse Chop sequence was designed to
eliminate the strong complementarity along the full length of the
binding site. Introduced mismatches are indicated with an ‘x’.
(TIF)
Figure S2 Kinetics of miR-615-3p decrease, CHOP
expression and cell death. (A) Sequence of the region
containing the predicted binding site for miR-615-3p in the
39UTR of the Chop transcript. (B) Apoptosis assessed by DAPI
stained nuclear morphology following treatment with vehicle
control (VC), 400 mM palmitate, or 1 mg/mL tunicamycin for
16 hours and 24 hours. Bars depict mean 6SEM, * p,0.05,
compared to VC, 24 h.
(TIF)
Figure S3 Antagonism of miR-615-3p does not increase
CHOP expression. Immunoblots for CHOP in (A) IRE-WT
and (B) Hepa1-6 cells transfected with either an antagomir to miR-
615-p or a negative control antagomir, and treated with vehicle
control (VC), 400 mM palmitate, or 1 mg/mL tunicamycin for
16 hours. Alpha-tubulin was used as loading control.
(TIF)
Data S1 MicroRNAs downregulated in IRE-WT (Vehicle
control versus palmitate).
(XLSX)
Data S2 MicroRNAs downregulated in IRE-WT (Vehicle
control versus tunicamycin).
(XLSX)
Data S3 MicroRNAs downregulated in IRE-KO (Vehicle
control versus palmitate).
(XLSX)
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